文献速递神经肿瘤

肿瘤相关星形胶质细胞通过QKI-5-SREBP2轴增强胆固醇合成支持胶质母细胞瘤生长

Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced QKI isoforms.
PubMed 文献 · Neuro Oncol · 2026-01-01

该研究揭示胶质母细胞瘤诱导肿瘤相关星形胶质细胞中RNA结合蛋白QKI从QKI-6向QKI-5亚型转换,QKI-5与SREBP2相互作用转录激活胆固醇代谢酶,促进星形胶质细胞来源胆固醇生成并支持GBM生长;敲低QKI-5或抑制SREBP2信号可抑制星形胶质细胞的促瘤效应。

要点

  • GBM诱导TAA中QKI亚型由QKI-6转换为QKI-5。
  • QKI-5与SREBP2互作激活胆固醇合成,促进GBM生长。
  • 靶向QKI-5-SREBP2轴或可抑制星形胶质细胞的促瘤作用。

核心结论

  • QKI-5通过QKI-5-SREBP2轴驱动星形胶质细胞代谢重编程,形成富胆固醇微环境支持GBM进展,靶向该通路具潜在治疗价值。

研究设计与样本

  • 对GBM相关星形胶质细胞行转录组与分子分析,并在人星形胶质细胞及与患者来源胶质瘤干样细胞共培养体系中进行QKI-5功能获得与缺失研究。
  • 采用体外增殖与成球实验及体内原位异种移植模型评估肿瘤生长,并用免疫沉淀与AlphaFold3结构预测研究QKI-5与SREBP2的机制互作。

主要发现

  • GBM诱导的QKI-5与SREBP2互作,转录激活胆固醇代谢酶,增强星形胶质细胞来源胆固醇生成并促进GBM生长。
  • 敲低QKI-5或使用SREBP2驱动信号抑制剂,可在体外和体内抑制星形胶质细胞介导的促瘤支持效应。

临床怎么用

  • QKI-5-SREBP2轴可作为潜在治疗靶点,敲低QKI-5或抑制SREBP2驱动信号可削弱星形胶质细胞的促瘤支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options. Tumor-associated astrocytes (TAAs) are crucial components of the GBM microenvironment, yet the contribution of alternative splicing (AS) in TAAs to tumor progression remains unclear. METHODS: Transcriptomic and molecular analyses of GBM-associated astrocytes revealed a GBM-induced isoform switch in the RNA-binding protein Quaking (QKI) from the QKI-6 isoform to QKI-5 isoform. The biological role of QKI-5 was examined through gain- and loss-of-function approaches in human astrocytes and coculture systems with patient-derived glioma stem-like cells (GSCs). In vitro proliferation and sphere-formation assays, along with in vivo orthotopic xenograft models, were used to evaluate tumor growth. Immunoprecipitation and AlphaFold3 structural prediction were performed to investigate the mechanistic interaction between QKI-5 and sterol regulatory element-binding protein 2 (SREBP2). RESULTS: GBM-induced QKI-5 interacts with SREBP2 to transcriptionally activate cholesterol metabolic enzymes, enhancing astrocyte-derived cholesterol production and promoting GBM growth. Knockdown of QKI-5 or inhibitors for SREBP2-driven signaling suppressed astrocyte-mediated tumor-supportive effects in vitro and in vivo. CONCLUSION: QKI-5 drives astrocytic metabolic reprogramming via the QKI-5-SREBP2 axis, fostering a cholesterol-rich tumor microenvironment that supports GBM progression. Targeting this pathway offers a potential therapeutic strategy.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Wu R, Yu X, Song X, et al. Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced QKI isoforms. Neuro Oncol. 2026. PMID: 41703645. doi:10.1093/neuonc/noag030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。